Related Experiment Videos
[Homocystinuria: case reports with a note on hyperhomocysteinemia as a risk factor for the early onset of vascular
1Klinika za pedijatriju Medicinskog fakulteta, Klinicki bolnicki centar Zagreb.
Lijecnicki Vjesnik
|July 1, 1994
Insights
Early diagnosis and treatment of homocystinuria, a genetic disorder caused by cystathionine beta-synthase deficiency, are crucial. This condition, marked by high homocysteine levels, increases the risk of early vascular disease.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Medicine
Background:
- Homocystinuria is an inherited metabolic disorder.
- It results from a deficiency in the enzyme cystathionine beta-synthase (CBS).
- Elevated homocysteine levels characterize this condition.
Observation:
- A family presented with three siblings affected by homocystinuria.
- Clinical presentation showed variability among affected individuals.
- The underlying cause was identified as cystathionine beta-synthase deficiency.
Findings:
- The study discusses potential treatment strategies for homocystinuria.
- Hyperhomocysteinemia was confirmed as a significant risk factor for premature vascular disease.
- Early diagnosis is essential for effective management and prevention of complications.
Implications:
- Highlights the importance of timely diagnosis in managing inherited metabolic disorders.
- Emphasizes the link between elevated homocysteine and early-onset cardiovascular issues.
- Informs clinical practice regarding genetic counseling and therapeutic interventions for homocystinuria.
Abstract:
Two brothers and a sister suffering from homocystinuria caused by cystathionine beta-synthase deficiency and the possibilities of treatment are presented. Possible clinical variability, the necessity for early diagnosis and the importance of hyperhomocysteinemia as a risk factor for early-onset vascular disease are discussed.